BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 426964)

  • 1. Haemodynamic effects of sodium nitroprusside in 21 subjects with congestive heart failure.
    Lukes SA; Romero CA; Resnekov L
    Br Heart J; 1979 Feb; 41(2):187-91. PubMed ID: 426964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulatory response to vasodilator therapy in congestive cardiomyopathy.
    Rossen RM; Alderman EL; Harrison DC
    Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
    Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
    Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemodynamic response to sodium nitroprusside in healthy people and in patients with left heart failure (author's transl)].
    Franke N; Peter K; Plaue R; van Ackern K
    Prakt Anaesth; 1978 Dec; 13(6):513-9. PubMed ID: 740633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic changes during sodium nitroprusside induced hypotension and halothane/nitrous oxide anaesthesia.
    Beierholm EA; Bredgaard Sørensen M; Sroczynski Z; Spotoft H; Gøthgen I; Thorshauge C
    Acta Anaesthesiol Scand; 1983 Apr; 27(2):99-103. PubMed ID: 6837256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined vasodilator therapy for chronic congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
    Beekman RH; Rocchini AP; Rosenthal A
    Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt CM; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
    Packer M; Meller J; Gorlin R; Herman MV
    Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside.
    Fifer MA; Colucci WS; Lorell BH; Jaski BE; Barry WH
    J Am Coll Cardiol; 1985 Mar; 5(3):731-7. PubMed ID: 3973272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
    Hermanovich J; Awan NA; Lui H; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
    Stemple DR; Kleiman JH; Harrison DC
    Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium nitroprusside therapy in congestive cardiomyopathy-variability in hemodynamic response.
    Mookherjee S; Henion W; Warner R; Eich RH; Smulyan H; Obeid AI
    J Clin Pharmacol; 1978 Jan; 18(1):67-75. PubMed ID: 338648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue AS
    Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haemodynamic effects during hypotension with sodium nitroprusside neurosurgery (author's transl)].
    Morr-Strathmann U; Schier U; Schilling A; Wendt M; Lawin P
    Prakt Anaesth; 1976 Dec; 11(6):378-81. PubMed ID: 1013050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aminophylline in refractory heart failure: a comparison to the vasodilator sodium nitroprusside, the old and the new.
    DiBianco R; Rosenfeld SP; Katz RJ; Simpson AG; Fletcher RD; Singh S
    Clin Cardiol; 1980 Aug; 3(4):268-75. PubMed ID: 7438579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.